Search Results - chaemin+lee

5 Results Sort By:
Multi Polish Robot Polishing Method
This invention is for a robotic system that is designed to polish multiple regions of a large optical surface simultaneously. It includes a novel internal propulsion mechanism that uses coils to drive a magnetic weight along a circular track. This method can accelerate the mirror fabrication time, eliminating the need for off-line testing, reducing...
Published: 12/1/2025   |   Updated: 12/1/2025   |   Inventor(s): Heejoo Choi, Kevin Derby, Casey Scoggins, Hyukmo Kang, Vipender Negi, Daewook Kim, Maxim Duque, Chaemin Lee
Keywords(s):  
Category(s): Technology Classifications > Imaging & Optics > Optical Fab / Metrology, Technology Classifications > Imaging & Optics > Lens & System Design, Technology Classifications > Engineering & Physical Sciences > Devices & Instrumentation > Robotics
Levonorgestrel Butanoate Formulation and Methods Relating Thereto
Description of Technology: This invention is a potential subcutaneous or intramuscular progestin-only, injectable contraceptive for women. Forty-five percent (45%) of pregnancies in the United States are unintended. In this group, one-third of reproductive age women are obese – increasing the risk of diabetes, hypertension and venous thromboembolism...
Published: 4/23/2026   |   Updated: 8/2/2023   |   Inventor(s): Min Lee, Diana Blithe, Jia-Hwa Fang, Eduardo Ruiz, Ken Chen
Keywords(s): Blithe, CONTRACEPTIVE, INJECTABLE, LB, Lee, Levonorgestrel, Levonorgestrel Butanoate, LNG, National Institute of Child Health and Human Development, NICHD, Steroidal Progestin
Category(s): TherapeuticArea > Endocrinology, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics, TherapeuticArea > Reproductive Health
Monomeric and Oligomeric Compounds as Contraceptives and Endocrine Therapeutics
Summary: NICHD is seeking research co-development partners and/or licensees for development of this invention as a male contraceptive. Description of Technology: The options for male contraceptives are limited. Research is ongoing to develop a male contraceptive based on hormonal activity. Testosterone is one of the hormones necessary in producing...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): Min Lee, Diana Blithe, Pranab Gupta, Bashir Kaskar, Ming-Teh Lin
Keywords(s): Blithe, CONTRACEPTIVE, Estrogenic Activity, Eunice Kennedy Shriver National Institute of Child Health an, Lee, Male Contraceptive, MONOMERIC, NCE, New Chemical Entity, NICHD, OLIGOMERIC
Category(s): Application > Therapeutics, TherapeuticArea > Reproductive Health, TherapeuticArea > Endocrinology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing
Nandrolone 17 Beta-Carbonates
Summary: Researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development are highly motivated in seeking licensing and/or collaboration partners for the development and use of androgenic compounds as contraceptives and/or hormonal therapeutics. Description of Technology: The available options for male contraceptives...
Published: 4/23/2026   |   Updated: 8/2/2023   |   Inventor(s): Richard Blye, Hyun Kim, Min Lee
Keywords(s): 19-nortestosterone, Androgenic Compounds, Blye, Male Contraceptive, Nandrolone, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Endocrinology, Collaboration Sought > Licensing, Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Reproductive Health
Modified Green Tea Polyphenol EGCG and EGCG-ester Inhibit Endospores
Modified Green Tea Polyphenol EGCG and EGCG-ester Inhibit EndosporesResearchers at Augusta University have invented skin-friendly compositions and methods for killing, inactivating, or otherwise reducing the bacterial endospores by using an effective amount of the green tea EGCG or its derivatives. EGCG research shows clear application for a hand sanitizer...
Published: 4/21/2023   |   Updated: 1/15/2021   |   Inventor(s): Stephen Hsu, Lee Lee, Tin-Chun Chu
Keywords(s):  
Category(s): Therapeutics